-
Loading metrics
Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A)
-
Thomas Prukop,
Roles Conceptualization, Data curation, Writing – original draft
Affiliations Max-Planck-Institute of Experimental Medicine, Department of Neurogenetics, Göttingen, Germany, University Medical Center Göttingen, Institute of Clinical Pharmacology, Göttingen, Germany
⨯ - Jan Stenzel,
- Stephanie Wernick,
- Theresa Kungl,
- Magdalena Mroczek,
- Julia Adam,
-
David Ewers,
Roles Data curation
Affiliation Max-Planck-Institute of Experimental Medicine, Department of Neurogenetics, Göttingen, Germany
⨯ - Serguei Nabirotchkin,
- Klaus-Armin Nave,
- Rodolphe Hajj,
- Daniel Cohen,
- Michael W. Sereda
http://orcid.org/0000-0001-8210-9277
Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A)
- Thomas Prukop,
- Jan Stenzel,
- Stephanie Wernick,
- Theresa Kungl,
- Magdalena Mroczek,
- Julia Adam,
- David Ewers,
- Serguei Nabirotchkin,
- Klaus-Armin Nave,
- Rodolphe Hajj
x
- Published: January 16, 2019
- https://doi.org/10.1371/journal.pone.0209752